154 related articles for article (PubMed ID: 19502161)
1. Commonly used animal models of non-alcoholic steatohepatitis.
Fan JG; Qiao L
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):233-40. PubMed ID: 19502161
[TBL] [Abstract][Full Text] [Related]
2. Animal models of NASH: getting both pathology and metabolic context right.
Larter CZ; Yeh MM
J Gastroenterol Hepatol; 2008 Nov; 23(11):1635-48. PubMed ID: 18752564
[TBL] [Abstract][Full Text] [Related]
3. Animal models of non-alcoholic steatohepatitis: of mice and man.
Schattenberg JM; Galle PR
Dig Dis; 2010; 28(1):247-54. PubMed ID: 20460919
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Miele L; Forgione A; Gasbarrini G; Grieco A
Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of NASH: animal models.
London RM; George J
Clin Liver Dis; 2007 Feb; 11(1):55-74, viii. PubMed ID: 17544972
[TBL] [Abstract][Full Text] [Related]
6. Dietary habits and nutrient intake in non-alcoholic steatohepatitis.
Toshimitsu K; Matsuura B; Ohkubo I; Niiya T; Furukawa S; Hiasa Y; Kawamura M; Ebihara K; Onji M
Nutrition; 2007 Jan; 23(1):46-52. PubMed ID: 17140767
[TBL] [Abstract][Full Text] [Related]
7. Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis.
Ayala I; Castillo AM; Adánez G; Fernández-Rufete A; Pérez BG; Castells MT
Exp Biol Med (Maywood); 2009 Jan; 234(1):10-6. PubMed ID: 18997102
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice.
Wouters K; van Bilsen M; van Gorp PJ; Bieghs V; Lütjohann D; Kerksiek A; Staels B; Hofker MH; Shiri-Sverdlov R
FEBS Lett; 2010 Mar; 584(5):1001-5. PubMed ID: 20114046
[TBL] [Abstract][Full Text] [Related]
9. Metabolic disturbances in non-alcoholic fatty liver disease.
Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies?
Lonardo A; Bellentani S; Ratziu V; Loria P
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):279-89. PubMed ID: 21476922
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of curcumin in non-alcoholic steatohepatitis.
Shapiro H; Bruck R
Nutr Res Rev; 2005 Dec; 18(2):212-21. PubMed ID: 19079906
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and therapy in NASH].
Tokushige K
Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic steatohepatitis: what can we learn from animal models?
Almonacid-Urrego CC; Sánchez-Campos S; Tuñón MJ; González-Gallego J
Curr Med Chem; 2012; 19(9):1389-404. PubMed ID: 22360487
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
Petta S; Muratore C; Craxì A
Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
[TBL] [Abstract][Full Text] [Related]
15. Chitosan ameliorates the severity of steatohepatitis induced by high fat diet in rats.
Zhou GD; Li MR; Zhang J; Pan D; Zhao SX; Yang JF; Yu J; Zhao JM
Scand J Gastroenterol; 2008; 43(11):1371-7. PubMed ID: 18654934
[TBL] [Abstract][Full Text] [Related]
16. The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis.
Ando H; Takamura T; Matsuzawa-Nagata N; Shima KR; Nakamura S; Kumazaki M; Kurita S; Misu H; Togawa N; Fukushima T; Fujimura A; Kaneko S
Biochem Biophys Res Commun; 2009 Mar; 380(3):684-8. PubMed ID: 19285022
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic steatohepatitis and animal models: understanding the human disease.
Varela-Rey M; Embade N; Ariz U; Lu SC; Mato JM; Martínez-Chantar ML
Int J Biochem Cell Biol; 2009 May; 41(5):969-76. PubMed ID: 19027869
[TBL] [Abstract][Full Text] [Related]
18. [Pathology of nonalcoholic steatohepatitis].
Jeen YM; Jin SY
Korean J Hepatol; 2009 Jun; 15(2):122-30. PubMed ID: 19581764
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
Marra F; Gastaldelli A; Svegliati Baroni G; Tell G; Tiribelli C
Trends Mol Med; 2008 Feb; 14(2):72-81. PubMed ID: 18218340
[TBL] [Abstract][Full Text] [Related]
20. Early-phase alcoholic liver disease: an update on animal models, pathology, and pathogenesis.
Ramaiah S; Rivera C; Arteel G
Int J Toxicol; 2004; 23(4):217-31. PubMed ID: 15371166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
